Cancer Research
Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer
Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.
Clinical Trial
Mar 28, 2026 1
Results for "Mesenchymal Stem Cell Therapy" in Cancer
20 articles
Cancer Research
CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Multiple Myeloma
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Stem Cell Memory CAR T Cells Achieve Remission Without Lymphodepletion in Blood Cancer
A first-in-human trial shows CAR-modified stem cell memory T cells outperform standard CAR T cells in expansion, persistence, and complete responses.
Research Paper
May 2, 2026 0
Cancer Research
New Cancer Treatment Targets Immune Cells to Fight Tumors More Effectively
Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.
Research Paper
Mar 30, 2026 0
Cancer Research
New CAR-T Cell Therapy Reprograms Tumor Environment to Fight Metastatic Cancer
Engineered immune cells target harmful macrophages in tumors, transforming the cancer environment to boost natural anti-tumor immunity.
Research Paper
Mar 29, 2026 1
Cancer Research
New CAR T Cell Therapy Targets Solid Tumors Without Needing Specific Cancer Antigens
Scientists develop CAR T cells that attack tumor-supporting immune cells, showing promise for treating hard-to-target solid cancers.
Research Paper
Mar 29, 2026 1
Cancer Research
Scientists Turn One Stem Cell Into 14 Million Cancer-Fighting NK Cells
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
Press Release
Mar 29, 2026 0
Cancer Research
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Cancer Research
Gene Therapy Delivers Immune Signals Directly Into Brain Tumors in First Human Trial
A phase 1 trial shows Temferon โ a gene-engineered stem cell therapy โ safely delivers interferon-ฮฑ into glioblastoma tumors with no dose-limiting toxicities.
Research Paper
Jun 2, 2026 0
Cancer Research
3D Spatial Transcriptomics Unmasks Hidden Immune Escape Zones in Bone Cancer
New 3-D spatial mapping reveals four distinct immune-evasion niches in osteosarcoma that explain why checkpoint therapies fail.
Research Paper
Apr 26, 2026 0
Cancer Research
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
Clinical Trial
Mar 29, 2026 0
Cancer Research
AstraZeneca's In Vivo CAR-T Shows Promise Against Multiple Myeloma Despite Safety Concerns
New trial data reveals AstraZeneca's experimental in vivo CAR-T therapy showed early responses in multiple myeloma patients but resulted in one death.
Press Release
Mar 28, 2026 1
Cancer Research
NK Cell Vesicles Deliver One-Two Punch Against Osteosarcoma Using Senolytics
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.
Research Paper
Apr 3, 2026 0
Cancer Research
Four Leukemic Stem Cell Subtypes Explain Venetoclax Resistance in AML
Researchers identify four LSC subtypes that predict venetoclax resistance and reveal matched subtype-specific therapies for AML patients.
Research Paper
May 9, 2026 0
Cancer Research
BCG Bladder Cancer Treatment Reprograms Bone Marrow to Boost Tumor Immunity
BCG therapy for bladder cancer travels to bone marrow, reprogramming stem cells to produce enhanced immune cells that fight tumors throughout the body.
Research Paper
Apr 2, 2026 0
Cancer Research
Leukemic Stem Cells Make Their Own Ketones to Dodge Cell Death
AML stem cells produce BHB via autonomous ketogenesis to block ferroptosis, revealing a targetable metabolic vulnerability in leukemia.
Research Paper
May 17, 2026 0
Cancer Research
CAR-T Cell Therapy Shows Promise Against Advanced Liver Cancer in Early Trial
Engineered immune cells target liver cancer protein in phase I safety study, though trial ended early with 10 patients.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Clinical Trial
Mar 29, 2026 12
Cancer Research
CAR-T Cell Therapy Shows Promise for Treatment-Resistant Blood Cancers
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Clinical Trial
Mar 28, 2026 0
Page 1 of 2Next